Breaking News Instant updates and real-time market news.

MNK

Mallinckrodt

$31.23

0.145 (0.47%)

15:53
11/14/18
11/14
15:53
11/14/18
15:53

FDA advisors back Mallinckrodt abuse-deterrent opioid, Bloomberg says

The FDA advisory panel voted 10-7 to back MNK-812, according to Bloomberg.

  • 14

    Nov

  • 14

    Nov

  • 16

    Nov

MNK Mallinckrodt
$31.23

0.145 (0.47%)

11/13/18
MZHO
11/13/18
NO CHANGE
Target $29
MZHO
Neutral
Mallinckrodt price target raised to $29 from $27 at Mizuho
Mizuho analyst Irina Koffler raised her price target for Mallinckrodt to $29 citing improved durability for Acthar and INOmax. The analyst says the tone at Mallinckrodt's marketing event last week on Acthar was "incrementally upbeat." However, she reiterates a Neutral rating on the shares.
11/06/18
WELS
11/06/18
NO CHANGE
Target $27
WELS
Market Perform
Mallinckrodt growth appears challenged in 2019, says Wells Fargo
Wells Fargo analyst David Maris noted that Mallinckrodt reported Q3 earnings that beat his and consensus estimates due to higher revenues and lower operating spending, but he is still modeling a 5% decline next year for the company's largest product, Acthar. Noting that view of Acthar, as well as considering share loss for Inomax and the company's leverage, Maris said he sees the shares as fairly valued and keeps a Market Perform rating on Mallinckrodt. Maris raised his price target on Mallinckrodt shares to $27 from $24 as he raised his 2018 EPS estimate to $7.13 from $6.82.
10/08/18
10/08/18
NO CHANGE
Target $24

Market Perform
Wells cuts Mallinckrodt target to $24 after confirming Praxair generic approval
Wells Fargo analyst David Maris says he confirmed this morning with Praxair (PX) that the device associated with generic Inomax has been approved. Praxair would not provide any additional details around the launch timing or pricing plans, Maris tells investors in a research note. The analyst lowered his price target for Mallinckrodt (MNK) shares to $24 from $30 after reducing his estimates to account for the generic taking approximately 20% share over the next several years. He models Mallinckrodt's Inomax going from a 5% grower to a slight decline. Maris admits, however, that there are "strong reasons" to think Inomax has a more defensible position than losing 20% share, such as a loyal installed base and a high service level. Nonetheless, he believes uncertainty around the generic device approval warrant a reduced outlook. The analyst keeps a Market Perform rating on Mallinckrodt. The stock in morning trading is down 5c to $25.83.
10/05/18
JEFF
10/05/18
NO CHANGE
Target $35
JEFF
Buy
Mallinckrodt 17% selloff yesterday 'well overdone,' says Jefferies
Jefferies analyst Anthony Petrone views the 17% selloff yesterday in shares of Mallinckrodt (MNK) as "well overdone." The pullback on Praxair's (PX) abbreviated new drug application clearance of Noxivent effectively prices in a $130M revenue shortfall on Mallinckrodt's INOmax in the near term, Petrone tells investors in a research note. Conversely, the analyst expects a more gradual erosion given the ongoing patent appeal process, potential label extension on INOmax, and the need for infrastructure investment on the part of Praxair. He keeps a Buy rating on Mallinckrodt with a $35 price target.

TODAY'S FREE FLY STORIES

12:05
08/19/19
08/19
12:05
08/19/19
12:05
General news
Treasury's $87 B 3- and 6-month bill auctions were mixed »

Treasury's $87 B 3-…

BMA

Banco Macro

$34.53

-3.75 (-9.80%)

12:00
08/19/19
08/19
12:00
08/19/19
12:00
Hot Stocks
Banco Macro falls -9.8% »

Banco Macro is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBAR

BBVA

$5.29

-0.575 (-9.80%)

12:00
08/19/19
08/19
12:00
08/19/19
12:00
Hot Stocks
BBVA falls -10.0% »

BBVA is down -10.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$10.29

-4.01 (-28.04%)

12:00
08/19/19
08/19
12:00
08/19/19
12:00
Hot Stocks
PG&E falls -27.9% »

PG&E is down -27.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$197.12

17.86 (9.96%)

12:00
08/19/19
08/19
12:00
08/19/19
12:00
Hot Stocks
Estee Lauder rises 9.9% »

Estee Lauder is up 9.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

MYOV

Myovant Sciences

$7.90

0.92 (13.18%)

12:00
08/19/19
08/19
12:00
08/19/19
12:00
Hot Stocks
Myovant Sciences rises 13.1% »

Myovant Sciences is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NM

Navios Maritime

$4.98

0.58 (13.18%)

12:00
08/19/19
08/19
12:00
08/19/19
12:00
Hot Stocks
Navios Maritime rises 13.3% »

Navios Maritime is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REPYY

Repsol

$0.00

(0.00%)

11:56
08/19/19
08/19
11:56
08/19/19
11:56
Downgrade
Repsol rating change  »

Repsol downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLM

Martin Marietta

$254.47

-0.27 (-0.11%)

11:56
08/19/19
08/19
11:56
08/19/19
11:56
Conference/Events
Martin Marietta management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 13

    Nov

GGAL

Grupo Financiero

$15.57

-2.14 (-12.08%)

11:55
08/19/19
08/19
11:55
08/19/19
11:55
Options
Grupo Financiero put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$56.25

0.7 (1.26%)

, RDS.B

Royal Dutch Shell

$56.37

0.815 (1.47%)

11:49
08/19/19
08/19
11:49
08/19/19
11:49
Downgrade
Royal Dutch Shell, Royal Dutch Shell rating change  »

Royal Dutch Shell…

RDS.A

Royal Dutch Shell

$56.25

0.7 (1.26%)

RDS.B

Royal Dutch Shell

$56.37

0.815 (1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:37
08/19/19
08/19
11:37
08/19/19
11:37
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

11:37
08/19/19
08/19
11:37
08/19/19
11:37
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

GFF

Griffon

$18.28

0.45 (2.52%)

11:33
08/19/19
08/19
11:33
08/19/19
11:33
Conference/Events
Griffon management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 23

    Sep

  • 25

    Sep

SPY

SPDR S&P 500 ETF Trust

$292.26

3.47 (1.20%)

, SPX

S&P 500

$0.00

(0.00%)

11:31
08/19/19
08/19
11:31
08/19/19
11:31
General news
Trump says Fed rate 'should be reduced by at least 100 basis points' »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$292.26

3.47 (1.20%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APO

Apollo Global

$34.20

2.17 (6.77%)

, TGNA

Tegna

$15.82

0.74 (4.91%)

11:29
08/19/19
08/19
11:29
08/19/19
11:29
Periodicals
Apollo tells Bloomberg didn't approach Tegna about selling stations to Tegna »

A spokesperson for Apollo…

APO

Apollo Global

$34.20

2.17 (6.77%)

TGNA

Tegna

$15.82

0.74 (4.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

BSET

Bassett Furniture

$12.48

0.49 (4.09%)

11:25
08/19/19
08/19
11:25
08/19/19
11:25
Conference/Events
Bassett Furniture management to meet with Sidoti »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

UBER

Uber

$35.52

0.3 (0.85%)

, SQ

Square

$64.15

1.24 (1.97%)

11:25
08/19/19
08/19
11:25
08/19/19
11:25
Periodicals
Uber names Melinda Roylett as new U.K. boss, Reuters reports »

Uber (UBER) has appointed…

UBER

Uber

$35.52

0.3 (0.85%)

SQ

Square

$64.15

1.24 (1.97%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 28

    Aug

  • 28

    Aug

  • 10

    Sep

  • 27

    Oct

  • 06

    Nov

WORK

Slack Technologies

$31.00

0.995 (3.32%)

11:25
08/19/19
08/19
11:25
08/19/19
11:25
Options
Slack call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

11:25
08/19/19
08/19
11:25
08/19/19
11:25
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

LDL

Lydall

$20.30

0.395 (1.98%)

11:20
08/19/19
08/19
11:20
08/19/19
11:20
Conference/Events
Lydall management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

HCSG

Healthcare Services

$22.26

0.17 (0.77%)

11:18
08/19/19
08/19
11:18
08/19/19
11:18
Conference/Events
Healthcare Services management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 10

    Sep

  • 11

    Sep

  • 19

    Sep

  • 13

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
08/19/19
08/19
11:17
08/19/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRAY

ViewRay

$4.51

0.07 (1.58%)

11:16
08/19/19
08/19
11:16
08/19/19
11:16
Recommendations
ViewRay analyst commentary at Piper Jaffray »

ViewRay prostate cancer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
08/19/19
08/19
11:16
08/19/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.